845 - Motif Bio #MTFB Strategic Minerals #SML Horizonte Minerals #HZM Connor Campbell & Alan Green

Aug 11, 2017, 11:43 AM

On The Vox Markets Podcast Today - 11th August 2017

Graham Lumsden, CEO of Motif Bio #MTFB talks about their recent milestone, the last patient completing the treatment in REVIVE-2, the second Phase 3 clinical trial, of it leads drug, Iclaprim. (Interview starts at 1 minute 50 seconds)

John Peters, Managing Director of Strategic Minerals #SML goes over some of the highlights of its quarter 2 update including record sales of magnetite at its Cobre operation. (Interview starts at 12 minutes 54 seconds)

Jeremy Martin, CEO of Horizonte Minerals #HZM goes over some of thei highlights from their interim results including having £5.6m cash, which means they are fully funded to complete their Feasibility Study and beyond. (Interview starts at 23 minutes)

Financial Analyst with Spreadex Connor Campbell talks about: Admiral #ADM Hikma Pharmaceuticals #HIK Kingfisher Group #KGF (Interview starts at 33 minutes 51 seconds)

Alan Green CEO of Brand Communications talks about: Andalas Energy & Power #ADL Avation #AVAP Cineworld #CINE (Interview starts at 46 minutes 5 seconds)

Plus the Top 5 Most Followed Companies on Vox Markets in the last 24 hours & the Top 5 Most Liked RNS’s on Vox Markets in the last 24 hours. (Feature starts at 58 minutes 50 seconds)

Vox Markets is revolutionising the way companies engage with shareholders and the stock market at large. By aggregating IR and digital content onto one secure and compliant platform, Vox Markets has established itself as the go-to resource for the investment community.

#VoxMarkets #StockMarket #LivePrices #StockMarketNews #Money #Investing #Finance #Business #Podcast